CTCE-9908 (TFA)
CTCE-9908 TFA is a potent and selective CXCR4 antagonist. CTCE-9908 TFA induces mitotic catastrophe, cytotoxicity and inhibits migration in CXCR4-expressing ovarian cancer cells[1][2].
Product Specifications
UNSPSC
12352209
Target
CXCR
Type
Peptides
Related Pathways
GPCR/G Protein; Immunology/Inflammation
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/ctce-9908-tfa.html
Solubility
H2O
Smiles
OC1=CC=C(C[C@@H](C(N[C@H](C(N[C@@H](CCCCNC([C@@H](NC([C@H](CC2=CC=C(O)C=C2)NC([C@@H](NC([C@@H](NC([C@@H](NC([C@@H](NC(CNC([C@H](CCCCN)N)=O)=O)C(C)C)=O)CO)=O)CC(C)C)=O)CO)=O)=O)CCCNC(N)=N)=O)C(N)=O)=O)CCCNC(N)=N)=O)NC([C@@H](NC([C@@H](NC([C@@H](NC([C@@H](NC(CNC([C@H](CCCCN)N)=O)=O)C(C)C)=O)CO)=O)CC(C)C)=O)CO)=O)C=C1.O=C(C(F)(F)F)O
Molecular Formula
C88H148F3N27O25
Molecular Weight
2041.28
References & Citations
[1]Joseph Kwong, et al. An antagonist of the chemokine receptor CXCR4 induces mitotic catastrophe in ovarian cancer cells. Mol Cancer Ther. 2009 Jul;8 (7) :1893-905.|[2]Saima Hassan, et al. CXCR4 peptide antagonist inhibits primary breast tumor growth, metastasis and enhances the efficacy of anti-VEGF treatment or docetaxel in a transgenic mouse model. Int J Cancer. 2011 Jul 1;129 (1) :225-32.
Shipping Conditions
Room temperature
Scientific Category
Peptides
Clinical Information
No Development Reported
Isoform
CXCR4
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
AP17775PU-N 400 µL
Transaldolase 1 (TALDO1) (Center) Rabbit Polyclonal Antibody
Sign In for Pricing
View Details 
BNC941773-500 1x 500 µL
Chromogranin A / CHGA (Neuroendocrine Marker) (CHGA/1773R), CF594 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
